Table 1.
Personal Demographics.
| 2020 Survey | # | % | 2021 Survey | # | % | P-value |
|---|---|---|---|---|---|---|
| Age (Years) | Age (Years) | |||||
| 25-34 | 130 | 14.5 | 25-34 | 33 | 12 | .311 |
| 35-44 | 344 | 38.4 | 35-44 | 90 | 32.7 | .104 |
| 45-54 | 245 | 27.4 | 45-54 | 87 | 31.6 | .149 |
| 55-64 | 150 | 16.8 | 55-64 | 51 | 18.5 | .460 |
| 65+ | 26 | 2.9 | 65+ | 11 | 4.0 | .353 |
| Sex | Sex | |||||
| Female | 55 | 6.2 | Female | 24 | 8.7 | .127 |
| Male | 826 | 93.8 | Male | 245 | 89.1 | .208 |
| Home demographics | Home demographics | |||||
| Spouse at home | 773 | 86.5 | Spouse at home | 231 | 84.0 | .486 |
| Children at home | Children at home | |||||
| 0 | 250 | 28.2 | 0 | 77 | 28.0 | .927 |
| 1 | 221 | 24.9 | 1 | 52 | 18.9 | .054 |
| 2 | 266 | 30.0 | 2 | 82 | 29.8 | .917 |
| 3 | 109 | 12.3 | 3 | 39 | 14.2 | .358 |
| 4+ | 41 | 4.6 | 4+ | 19 | 6.9 | .119 |
| Estimated home city population | Estimated home city population | |||||
| <100,000 | 46 | 5.2 | <100,000 | 15 | 5.5 | .816 |
| 100,000-500,000 | 185 | 20.7 | 100,000-500,000 | 45 | 16.4 | .129 |
| 500,000-1,000,000 | 136 | 15.2 | 500,000-1,000,000 | 42 | 15.3 | .937 |
| 1,000,000-2,000,000 | 144 | 16.1 | 1,000,000-2,000,000 | 51 | 18.5 | .314 |
| >2,000,000 | 382 | 42.8 | >2,000,000 | 117 | 42.5 | .954 |
| Geographic region | Geographic region | |||||
| Africa | 44 | 5.0 | Africa | 14 | 5.1 | .886 |
| Asia | 213 | 24.2 | Asia | 74 | 26.9 | .265 |
| Australia | 8 | 0.9 | Australia | 2 | 0.7 | .801 |
| Europe | 242 | 27.5 | Europe | 75 | 27.3 | .885 |
| Middle east | 77 | 8.7 | Middle east | 36 | 13.1 | .025 |
| North America | 152 | 17.3 | North America | 25 | 9.1 | <.002 |
| South America/Latin America | 145 | 16.5 | South America/Latin America | 49 | 17.8 | .495 |
| Medical comorbidities | Medical comorbidities | |||||
| Obesity | 103 | 11.4 | Obesity | 35 | 12.7 | .555 |
| Hypertension | 156 | 17.3 | Hypertension | 46 | 16.7 | .827 |
| Tobacco use | 77 | 8.5 | Tobacco use | 14 | 5.1 | .061 |
| Diabetes | 45 | 5.0 | Diabetes | 16 | 5.8 | .587 |
| Respiratory illness | 35 | 3.9 | Respiratory illness | 12 | 4.4 | .687 |
| Renal failure | 5 | 0.6 | Renal failure | 4 | 1.5 | .269 |
| Cancer | 4 | 0.4 | Cancer | 2 | 0.7 | .924 |
| Cardiac disease | 25 | 2.8 | Cardiac disease | 7 | 2.5 | .992 |
| No comorbidities | 570 | 63.2 | No comorbidities | 186 | 67.6 | .178 |
| Total respondents | 902 | 100 | Total respondents | 275 | 100 | |
Calculation of P-values was performed using chi-square, Fisher's exact test, and ANOVA.
Bolded values indicate statistical significance at P < .05.
# = number of respondents/votes, % = percent, ± SD = standard deviation.